ເດືອນຕຸລາ 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) ໄດ້ຮັບການອະນຸມັດຈາກອົງການອາຫານ ແລະຢາສຳລັບຄົນເຈັບຜູ້ໃຫຍ່ ແລະເດັກນ້ອຍທີ່ມີອາຍຸ 12 ປີຂຶ້ນໄປ ຜູ້ທີ່ມີ thyroi ກ້າວຫນ້າທາງດ້ານທ້ອງຖິ່ນ ຫຼື metastatic ແຕກຕ່າງກັນ..
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..